Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ALK Digital Pathology Outcome Prediction

NCT06846736 is registered in ClinicalTrials.gov with Sheba Medical Center as lead sponsor.

NCT NCT06846736
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06846736 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ALK Digital Pathology Outcome Prediction
Lead sponsor
Sheba Medical Center
Phase
Observational
Overall status
Enrolling by invitation
Start date
August 13, 2023
Completion date
December 1, 2028
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alk-inhibitor treated, alk-positive non-small cell lung cancer